ES2185790T3 - Sintesis en un solo recipiente de derivados de 2-oxazolidinona. - Google Patents
Sintesis en un solo recipiente de derivados de 2-oxazolidinona.Info
- Publication number
- ES2185790T3 ES2185790T3 ES96926465T ES96926465T ES2185790T3 ES 2185790 T3 ES2185790 T3 ES 2185790T3 ES 96926465 T ES96926465 T ES 96926465T ES 96926465 T ES96926465 T ES 96926465T ES 2185790 T3 ES2185790 T3 ES 2185790T3
- Authority
- ES
- Spain
- Prior art keywords
- formula compound
- formula
- synthesis
- single container
- oxazolidinone derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000015572 biosynthetic process Effects 0.000 title abstract 3
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 9
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 abstract 1
- 238000006641 Fischer synthesis reaction Methods 0.000 abstract 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 abstract 1
- 150000002148 esters Chemical group 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- DAZXVJBJRMWXJP-UHFFFAOYSA-N n,n-dimethylethylamine Chemical compound CCN(C)C DAZXVJBJRMWXJP-UHFFFAOYSA-N 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Indole Compounds (AREA)
Abstract
LA INVENCION ACTUAL PROPORCIONA UN PROCESO MEJORADO PARA LA PREPARACION DE (S) 1H INDOL FORMACION DE UN CARBAMATO DE FORMULA (III), A PARTIR DE CLORHIDRATO DE METIL 4 DEL COMPUESTO DE FORMULA (III) PARA LOGRAR EL COMPUESTO DE FORMULA (IV); C) REDUCCION DEL GRUPO ESTER DE METILO EN EL COMPUESTO DE FORMULA (IV) PARA OBTENER EL COMPUESTO DE FORMULA (V); D) CIERRE DEL ANILLO DEL COMPUESTO DE FORMULA (V) PARA OBTENER EL COMPUESTO DE FORMULA (VI); E) FORMACION DE SAL DE DIAZONIO A PARTIR DEL COMPUESTO DE FORMULA (VI) SEGUIDA DE REDUCCION PARA OBTENER EL COMPUESTO DE FORMULA (VII); F) REACCION DE FISCHER DEL COMPUESTO DE FORMULA (VII) PARA OBTENER (S) [2 -(DIMETILAMINO)ETIL] OLIDINONA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9516145.1A GB9516145D0 (en) | 1995-08-07 | 1995-08-07 | Improved chemical synthesis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2185790T3 true ES2185790T3 (es) | 2003-05-01 |
Family
ID=10778867
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES02008427T Expired - Lifetime ES2261545T3 (es) | 1995-08-07 | 1996-08-02 | Procedimiento para la purificacion de (s)-4-((3-(dimetilamino)etil)-1h-indol-5-il)metil)-2-oxazolidinona. |
| ES96926465T Expired - Lifetime ES2185790T3 (es) | 1995-08-07 | 1996-08-02 | Sintesis en un solo recipiente de derivados de 2-oxazolidinona. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES02008427T Expired - Lifetime ES2261545T3 (es) | 1995-08-07 | 1996-08-02 | Procedimiento para la purificacion de (s)-4-((3-(dimetilamino)etil)-1h-indol-5-il)metil)-2-oxazolidinona. |
Country Status (34)
| Country | Link |
|---|---|
| US (2) | US6084103A (es) |
| EP (2) | EP0843672B1 (es) |
| JP (6) | JP3729503B2 (es) |
| KR (1) | KR100670704B1 (es) |
| CN (3) | CN1092657C (es) |
| AR (2) | AR006515A1 (es) |
| AT (2) | ATE325121T1 (es) |
| AU (1) | AU718413B2 (es) |
| BR (1) | BR9609830A (es) |
| CA (2) | CA2227039C (es) |
| CZ (2) | CZ293050B6 (es) |
| DE (2) | DE69624825T2 (es) |
| DK (2) | DK0843672T3 (es) |
| ES (2) | ES2261545T3 (es) |
| GB (1) | GB9516145D0 (es) |
| HK (1) | HK1047094B (es) |
| HU (1) | HU229966B1 (es) |
| IL (4) | IL156733A (es) |
| IN (2) | IN185148B (es) |
| MX (1) | MX9801044A (es) |
| MY (1) | MY117571A (es) |
| NO (2) | NO311690B1 (es) |
| NZ (1) | NZ315040A (es) |
| PL (1) | PL188805B1 (es) |
| PT (2) | PT1227095E (es) |
| RO (2) | RO121816B1 (es) |
| RU (1) | RU2167875C2 (es) |
| SI (2) | SI0843672T1 (es) |
| SK (1) | SK285052B6 (es) |
| TR (1) | TR199800182T1 (es) |
| TW (1) | TW358811B (es) |
| UA (1) | UA53625C2 (es) |
| WO (1) | WO1997006162A1 (es) |
| ZA (1) | ZA966711B (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5851400A (en) * | 1999-07-09 | 2001-01-30 | Chugai Seiyaku Kabushiki Kaisha | Process for the preparation of aniline derivatives |
| GB9928578D0 (en) * | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Pharmaceutical formulations |
| ES2204302B2 (es) * | 2002-08-07 | 2005-03-01 | Laboratorios Vita, S.A. | Procedimiento para la obtencion de un compuesto farmaceuticamente activo. |
| US20070173536A1 (en) * | 2004-02-06 | 2007-07-26 | Ciba Specialty Chemicals Holding Inc. | Crystalline forms of zolmitriptan |
| WO2006055964A2 (en) * | 2004-11-19 | 2006-05-26 | Teva Pharmaceutical Industries Ltd. | Zolmitriptan crystal forms |
| CN101248184B (zh) | 2005-08-25 | 2013-01-16 | 宇部兴产株式会社 | 光学活性（S或R）-α-氨基酸及光学活性（S或R）-α-氨基酸酯的制造方法 |
| ATE510836T1 (de) * | 2006-01-19 | 2011-06-15 | Matrix Lab Ltd | Umwandlung eines aromatischen diazoniumsalzes in ein arylhydrazin |
| WO2008007390A2 (en) * | 2006-07-10 | 2008-01-17 | Natco Pharma Limited | An improved process for purification of zolmitriptan |
| WO2008018090A2 (en) * | 2006-08-09 | 2008-02-14 | Matrix Laboratories Ltd | An improved process for the preparation of zolmitriptan |
| CZ301538B6 (cs) * | 2007-02-26 | 2010-04-07 | Zentiva, A. S. | Zpusob prípravy zolmitriptanu |
| CZ2007158A3 (cs) * | 2007-02-26 | 2008-10-22 | Zentiva, A. S. | Zpusob prípravy zolmitriptanu |
| JP2010540613A (ja) * | 2007-10-03 | 2010-12-24 | ジェネリクス・（ユーケー）・リミテッド | ゾルミトリプタン、その塩、及びその溶媒和物の調製方法 |
| CN101230047B (zh) * | 2008-02-04 | 2010-08-04 | 江苏中威药业有限公司 | 一种4-取代手性噁唑烷酮类化合物的制备方法 |
| US8906949B2 (en) | 2010-05-21 | 2014-12-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Orally disintegrating tablets of zolmitriptan and process for preparing the same |
| CN101948443B (zh) * | 2010-08-17 | 2012-08-22 | 河南师范大学 | 一种简单、高效合成4-取代噁唑烷酮衍生物的方法 |
| EP2691396B1 (en) | 2011-03-30 | 2016-08-10 | Brown University | Enopeptins, uses thereof, and methods of synthesis thereto |
| WO2013057739A2 (en) * | 2011-09-02 | 2013-04-25 | Emcure Pharmaceuticals Limited | An improved process for preparation of zolmitriptan |
| CN102964270B (zh) * | 2012-11-21 | 2015-01-07 | 合肥星宇化学有限责任公司 | 一种亚硫酸钠还原重氮盐合成肼的方法 |
| CN103275075B (zh) * | 2013-06-24 | 2015-01-07 | 成都天台山制药有限公司 | 佐米曲普坦及其制备方法 |
| WO2016037072A2 (en) * | 2014-09-04 | 2016-03-10 | Brown University | Enopeptin analogas and methods of use thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3879410A (en) * | 1971-02-08 | 1975-04-22 | Messrs Lab Guidotti & C S P A | 4-Aryl-4-oxazolin-2-ones exhibiting myotonic and myorelaxing activity |
| GB1478108A (en) * | 1975-10-30 | 1977-06-29 | Nippon Chemipar Co Ltd | 5-benzyl-2-oxazolidone derivatives and a process for producing the same |
| GB8724912D0 (en) * | 1987-10-23 | 1987-11-25 | Wellcome Found | Indole derivatives |
| DK0486666T3 (da) * | 1990-06-07 | 1998-03-30 | Zeneca Ltd | Terapeutisk heterocykliske forbindelser |
| GB9012672D0 (en) * | 1990-06-07 | 1990-08-01 | Wellcome Found | Therapeutic heterocyclic compounds |
| GB9401436D0 (en) * | 1994-01-26 | 1994-03-23 | Wellcome Found | Therapeutic heterocyclic compounds |
| GB9423682D0 (en) * | 1994-11-23 | 1995-01-11 | Merck Sharp & Dohme | Therapeutic agents |
| CA2207201A1 (en) * | 1994-12-06 | 1996-06-13 | Caroline Henry | Azetidine, pyrrolidine and piperidine derivatives as 5ht1 receptor agonists |
-
1995
- 1995-08-07 GB GBGB9516145.1A patent/GB9516145D0/en active Pending
-
1996
- 1996-02-08 UA UA98031096A patent/UA53625C2/uk unknown
- 1996-08-02 RU RU98104085/04A patent/RU2167875C2/ru active
- 1996-08-02 US US09/011,045 patent/US6084103A/en not_active Expired - Lifetime
- 1996-08-02 DE DE69624825T patent/DE69624825T2/de not_active Expired - Lifetime
- 1996-08-02 AT AT02008427T patent/ATE325121T1/de active
- 1996-08-02 TR TR1998/00182T patent/TR199800182T1/xx unknown
- 1996-08-02 EP EP96926465A patent/EP0843672B1/en not_active Expired - Lifetime
- 1996-08-02 ES ES02008427T patent/ES2261545T3/es not_active Expired - Lifetime
- 1996-08-02 JP JP50822697A patent/JP3729503B2/ja not_active Expired - Lifetime
- 1996-08-02 DE DE69636107T patent/DE69636107T2/de not_active Expired - Lifetime
- 1996-08-02 SK SK154-98A patent/SK285052B6/sk not_active IP Right Cessation
- 1996-08-02 PT PT02008427T patent/PT1227095E/pt unknown
- 1996-08-02 DK DK96926465T patent/DK0843672T3/da active
- 1996-08-02 EP EP02008427A patent/EP1227095B1/en not_active Expired - Lifetime
- 1996-08-02 PL PL96324881A patent/PL188805B1/pl unknown
- 1996-08-02 IL IL156733A patent/IL156733A/en not_active IP Right Cessation
- 1996-08-02 HU HU9900188A patent/HU229966B1/hu unknown
- 1996-08-02 CA CA002227039A patent/CA2227039C/en not_active Expired - Lifetime
- 1996-08-02 BR BR9609830A patent/BR9609830A/pt not_active Application Discontinuation
- 1996-08-02 CZ CZ1998352A patent/CZ293050B6/cs not_active IP Right Cessation
- 1996-08-02 DK DK02008427T patent/DK1227095T3/da active
- 1996-08-02 RO ROA200400914A patent/RO121816B1/ro unknown
- 1996-08-02 NZ NZ315040A patent/NZ315040A/xx not_active IP Right Cessation
- 1996-08-02 MX MX9801044A patent/MX9801044A/es unknown
- 1996-08-02 CN CN96197237A patent/CN1092657C/zh not_active Expired - Lifetime
- 1996-08-02 SI SI9630560T patent/SI0843672T1/xx unknown
- 1996-08-02 KR KR1019980700833A patent/KR100670704B1/ko not_active Expired - Lifetime
- 1996-08-02 CZ CZ20031498A patent/CZ301603B6/cs not_active IP Right Cessation
- 1996-08-02 CA CA2572508A patent/CA2572508C/en not_active Expired - Lifetime
- 1996-08-02 SI SI9630738T patent/SI1227095T1/sl unknown
- 1996-08-02 AT AT96926465T patent/ATE227723T1/de active
- 1996-08-02 CN CNB01112010XA patent/CN1142904C/zh not_active Expired - Lifetime
- 1996-08-02 CN CNB011330929A patent/CN1244579C/zh not_active Expired - Lifetime
- 1996-08-02 IL IL148030A patent/IL148030A/en not_active IP Right Cessation
- 1996-08-02 RO RO98-00214A patent/RO119618B1/ro unknown
- 1996-08-02 ES ES96926465T patent/ES2185790T3/es not_active Expired - Lifetime
- 1996-08-02 WO PCT/GB1996/001885 patent/WO1997006162A1/en not_active Ceased
- 1996-08-02 AU AU66634/96A patent/AU718413B2/en not_active Expired
- 1996-08-02 IL IL12317196A patent/IL123171A/xx not_active IP Right Cessation
- 1996-08-02 PT PT96926465T patent/PT843672E/pt unknown
- 1996-08-06 MY MYPI96003220A patent/MY117571A/en unknown
- 1996-08-06 IN IN1742DE1996 patent/IN185148B/en unknown
- 1996-08-07 ZA ZA9606711A patent/ZA966711B/xx unknown
- 1996-08-07 AR ARP960103909A patent/AR006515A1/es active IP Right Grant
- 1996-10-01 TW TW085111923A patent/TW358811B/zh not_active IP Right Cessation
-
1998
- 1998-02-06 NO NO19980522A patent/NO311690B1/no not_active IP Right Cessation
- 1998-08-19 HK HK02108548.8A patent/HK1047094B/en not_active IP Right Cessation
-
2000
- 2000-02-02 US US09/496,409 patent/US6160123A/en not_active Expired - Lifetime
- 2000-04-25 IN IN454DE2000 patent/IN189756B/en unknown
- 2000-10-16 NO NO20005187A patent/NO311691B1/no not_active IP Right Cessation
-
2001
- 2001-07-27 JP JP2001228782A patent/JP3739678B2/ja not_active Expired - Lifetime
- 2001-07-27 JP JP2001228781A patent/JP2002037786A/ja not_active Withdrawn
-
2002
- 2002-02-06 IL IL14803002A patent/IL148030A0/xx unknown
- 2002-03-26 JP JP2002086955A patent/JP2002308858A/ja not_active Withdrawn
-
2003
- 2003-05-02 AR ARP030101543A patent/AR046236A2/es active IP Right Grant
-
2005
- 2005-11-18 JP JP2005334990A patent/JP4634286B2/ja not_active Expired - Lifetime
-
2006
- 2006-05-31 JP JP2006152810A patent/JP2006225406A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2185790T3 (es) | Sintesis en un solo recipiente de derivados de 2-oxazolidinona. | |
| Bredenkamp et al. | The chiral synthesis of thiazole amino acid enantiomers | |
| RU94046105A (ru) | АНАЛОГИ γ -АМИНОМАСЛЯНОЙ КИСЛОТЫ И L-ГЛУТАМИНОВОЙ КИСЛОТЫ И СПОСОБЫ ИХ ПОЛУЧЕНИЯ | |
| MY121760A (en) | Benzothiazin and benzoxazin derivatives;their preparation and uses | |
| KR910011891A (ko) | 펩티드 화합물, 이의 제조방법 및 이를 함유하는 약학적 조성물 | |
| IE801713L (en) | N-(3-mercapto-2-alkyl-1-oxopropyl)-2,¹3-dihydro-1h-indole-2-carboxylic acids | |
| DE60320766D1 (de) | Synthese von indolthiazolverbindungen als liganden des ah-rezeptors | |
| IL127058A0 (en) | Improved process for the synthesis of protected esters of (s)-3,4-dihydroxybutyric acid | |
| SK1694A3 (en) | Pyrolidine derivatives, preparation thereof and drugs containing same | |
| KR880003958A (ko) | 신규 세펨화합물 및 그의 제조방법 | |
| HU9400869D0 (en) | New indol derivatives pharmaceutical compositions containing them, and process for producing them | |
| Boibessot et al. | Advances in the synthesis of α-quaternary α-ethynyl α-amino acids | |
| KR950701904A (ko) | 치환된(아릴알콕시벤질)아미노프로판아미드 유도체, 이의 제조방법 및 항간질제, 신경보호제 및 항우울증제로서의 이의 용도[Substituted(arylalkoxybenzyl) aminopropanamide derivatives, their preparation and use as anti-epileptic neuroprotective and antidepressant agents] | |
| BR9905981A (pt) | Compostos isocromano e processos para a sua produção. | |
| IE55872B1 (en) | Derivatives of omega-amino acids,the preparation and utilisation thereof,and the compositions containing these derivatives | |
| KR920006318A (ko) | 치환된-4-아미노-3-피리디놀, 이의 제조방법 및 이를 포함하는 약제로서의 이의 용도 | |
| CO4700282A1 (es) | Compuestos | |
| Bach et al. | N-acyl-5, 5-dimethyl-oxazolidin-2-ones as latent aldehyde equivalents | |
| KR910007912A (ko) | 피리돈의 신규 유도체, 이들의 제조 방법, 신규 중간체, 약제로서 이들의 용도 및 이들을 함유한 조성물 | |
| Yuki et al. | Studies on Antiviral Agents. III. Synthesis of Tenuazonic Acid Derivatives. | |
| CA2194119A1 (en) | Process for the preparation of 2-substituted 5-chloroimidazole-4-carbaldehydes | |
| ATE221517T1 (de) | Herstellung von aminohalogencrotonaten | |
| Paulini et al. | Synthesis of Dipeptides Containing Novel Cyclopropyl‐and Cyclopropenyl‐Substituted β‐and γ‐Amino Acids | |
| PT74732A (de) | Neue indol-derivate verfahren zu ihrer herstellung und pharmazeutische praeparate die diese verbindung enthalten | |
| Lüsch et al. | New access to the synthetic building block l-aspartic acid β-semialdehyde via Grignard reaction |